PPA Technologies is developing a technical solution for active support in cases of cardiac insufficiency and complete temporary support during cardiac arrest. This technology could be complementary to the Myotech Circulatory Support System (CSS), which is intended to improve the treatment of acute heart failure.
John Lanzafame, Biophan’s CEO, said: “We have entered into this agreement to explore the potential for collaboration between the two companies, to strengthen our product offerings and infrastructure.”